InvestorsHub Logo
Followers 828
Posts 119319
Boards Moderated 16
Alias Born 09/05/2002

Re: tigerpac post# 196

Wednesday, 04/04/2018 1:33:09 PM

Wednesday, April 04, 2018 1:33:09 PM

Post# of 281
This means BMY can now start enrolling patients in multiple pivotal trials of Opdivo + NKTR-214, as previously described.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTR News